Chief Operating Officer (15) · PALISADE BIO, INC. (PALI)

Robert McRae

A named executive officer of PALISADE BIO in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$199,422

Salary $145,833Stock awards $24,850

FY2022: $500,487

3rd of 3 named executive officers at Palisade BIO by FY2023 total.

5 named officers on file for PALISADE BIO, FY2023

Robert McRae’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PALISADE BIO’s whole pay program stands against its peers

  • PALISADE BIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PALI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 22, 2024 (DEF 14A).

Free

Get Robert McRae’s full pay file as a PDF — free

More than this page: up to 10 years of Robert’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Robert McRae compensation by year

PALISADE BIO Summary Compensation Table · all 2 fiscal years held
In US dollars, as PALISADE BIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$350,000$145,833
Bonus$0$0
Stock awards$0$24,850
Option awards$61,067$739
Non-equity incentive$89,420$0
Pension and deferred compensation$0$0
All other$0$28,000
Total$500,487$199,422

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PALISADE BIO, INC. DEF 14A filed May 22, 2024, accession 0001493152-24-021034, and prior-year filings. Open the filing on EDGAR.

How this page was built: the PALISADE BIO, INC. filed document, accession 0001493152-24-021034. Every figure is read from that document and cited to the page and table it appears in. Filed May 22, 2024.

$500K
$199K
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
PSU1,192$10,549—
RSU400$3,540—
RSU44$389—
Option600—$36.00
Option40—$787.50

Per the Outstanding Equity Awards at Fiscal Year-End table in PALISADE BIO, INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

PALISADE BIO’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
J.D FinleyChief Executive Officer and Chief Financial Officer (5)$1,277,100
Mitchell JonesChief Medical Officer$458,024
Robert McRae · this pageChief Operating Officer (15)$199,422
Thomas HallamFormer Chief Executive Officer (3)—
Michael DawsonFormer Chief Medical Officer (13)—

The full PALISADE BIO compensation record

free company brief

This page is one person within PALISADE BIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PALISADE BIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Robert McRae's compensation dossier · One-time report. No refunds.